Amgen Inc AMGN
Revenue Intelligence Report • 70 quarters of SEC filing data • Updated 2026-03-06
Amgen Inc's revenue is primarily driven by its strategic investments in selling, general, and administrative (SG&A) expenses, with each dollar spent generating an impressive $11.11 in long-run revenue. Despite a holdout test revealing a 6.1% prediction error, the company's model demonstrates a solid accuracy of 2.5% MAPE, indicating reliable forecasting capabilities. For the upcoming fiscal year, Amgen is projecting a revenue of $36 billion, reflecting a slight decline of 1.2% year-over-year. Investors should consider the company's strong ROI on SG&A spending as a key factor in its revenue generation potential, while remaining mindful of the anticipated revenue dip.
Revenue Forecast
Quarterly Detail
| Quarter | Model Forecast | Actual | 95% Range | YoY Growth | Status |
|---|---|---|---|---|---|
| Q4 2025 | $9B | $10B | $9B – $10B | +2.0% | ✗ Outside range |
| Q2 2026 | $9B | $8B – $9B | +10.3% | ||
| Q3 2026 | $9B | $9B – $10B | -0.1% | ||
| Q4 2026 | $9B | $8B – $10B | -4.0% | ||
| Q1 2027 | $9B | $8B – $10B | -8.8% |
How Spending Drives Revenue
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch